Trial Information
Inclusion Criteria:
- Patients visiting the Sheba Medical Center pigmented lesion clinic for skin
examination
- Patients having at least three banal-appearing nevi, one on the upper back, one on
the lower back and one on the lower extremity (excluding foot), which are amenable
for RCM examination.
Exclusion Criteria:
- Patients who are unwilling or medically unable to lie down for 30 minutes.
- Pregnant women
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Inter-rater agreement on assignment of nevi to RCM patterns (baseline and follow-up images).
Outcome Time Frame:
3 YEARS
Safety Issue:
No
Principal Investigator
ALON SCOPE, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Sheba Medical Center
Authority:
Israel: Israeli Health Ministry Pharmaceutical Administration
Study ID:
SHEBA-10-8015-AS-CTIL
NCT ID:
NCT01194947
Start Date:
September 2010
Completion Date:
September 2013
Related Keywords:
- Common Melanocytic Nevi
- banal-appearing nevi
- NEVUS
- Nevus
- Nevus, Pigmented
- Nevus, Epithelioid and Spindle Cell